409 related articles for article (PubMed ID: 23434349)
41. Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice.
Zou Y; Song Y; Yang W; Meng F; Liu H; Zhong Z
J Control Release; 2014 Nov; 193():154-61. PubMed ID: 24852094
[TBL] [Abstract][Full Text] [Related]
42. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
[TBL] [Abstract][Full Text] [Related]
43. Alendronate-conjugated amphiphilic hyperbranched polymer based on Boltorn H40 and poly(ethylene glycol) for bone-targeted drug delivery.
Chen H; Li G; Chi H; Wang D; Tu C; Pan L; Zhu L; Qiu F; Guo F; Zhu X
Bioconjug Chem; 2012 Sep; 23(9):1915-24. PubMed ID: 22946621
[TBL] [Abstract][Full Text] [Related]
44. Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity.
Tam YT; Gao J; Kwon GS
J Am Chem Soc; 2016 Jul; 138(28):8674-7. PubMed ID: 27374999
[TBL] [Abstract][Full Text] [Related]
45. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
[TBL] [Abstract][Full Text] [Related]
46. Functionalized nanospheres for targeted delivery of paclitaxel.
Bushman J; Vaughan A; Sheihet L; Zhang Z; Costache M; Kohn J
J Control Release; 2013 Nov; 171(3):315-21. PubMed ID: 23792807
[TBL] [Abstract][Full Text] [Related]
47. Linear-dendritic copolymer composed of polyethylene glycol and all-trans-retinoic acid as drug delivery platform for paclitaxel against breast cancer.
Li J; Jiang X; Guo Y; An S; Kuang Y; Ma H; He X; Jiang C
Bioconjug Chem; 2015 Mar; 26(3):418-26. PubMed ID: 25675244
[TBL] [Abstract][Full Text] [Related]
48. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.
Zhao BJ; Ke XY; Huang Y; Chen XM; Zhao X; Zhao BX; Lu WL; Lou JN; Zhang X; Zhang Q
J Drug Target; 2011 Jun; 19(5):382-90. PubMed ID: 20677914
[TBL] [Abstract][Full Text] [Related]
49. Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy.
Zhu J; Huo Q; Xu M; Yang F; Li Y; Shi H; Niu Y; Liu Y
Nanoscale; 2018 Oct; 10(38):18387-18397. PubMed ID: 30256367
[TBL] [Abstract][Full Text] [Related]
50. In vitro and in vivo evaluation of APRPG-modified angiogenic vessel targeting micelles for anticancer therapy.
Guo P; Song S; Li Z; Tian Y; Zheng J; Yang X; Pan W
Int J Pharm; 2015; 486(1-2):356-66. PubMed ID: 25840274
[TBL] [Abstract][Full Text] [Related]
51. pH-Responsive Poly(Ethylene Glycol)-block-Polylactide Micelles for Tumor-Targeted Drug Delivery.
Xiao L; Huang L; Moingeon F; Gauthier M; Yang G
Biomacromolecules; 2017 Sep; 18(9):2711-2722. PubMed ID: 28774173
[TBL] [Abstract][Full Text] [Related]
52. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J
Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009
[TBL] [Abstract][Full Text] [Related]
53. Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links.
Koo AN; Min KH; Lee HJ; Lee SU; Kim K; Kwon IC; Cho SH; Jeong SY; Lee SC
Biomaterials; 2012 Feb; 33(5):1489-99. PubMed ID: 22130564
[TBL] [Abstract][Full Text] [Related]
54. In Vivo Evaluation of Reduction-Responsive Alendronate-Hyaluronan-Curcumin Polymer-Drug Conjugates for Targeted Therapy of Bone Metastatic Breast Cancer.
Wang K; Guo C; Dong X; Yu Y; Wang B; Liu W; Chen D
Mol Pharm; 2018 Jul; 15(7):2764-2769. PubMed ID: 29792799
[TBL] [Abstract][Full Text] [Related]
55. Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel.
Shahin M; Ahmed S; Kaur K; Lavasanifar A
Biomaterials; 2011 Aug; 32(22):5123-33. PubMed ID: 21501865
[TBL] [Abstract][Full Text] [Related]
56. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.
Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X
Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419
[TBL] [Abstract][Full Text] [Related]
57. A novel truncated basic fibroblast growth factor fragment-conjugated poly (ethylene glycol)-cholesterol amphiphilic polymeric drug delivery system for targeting to the FGFR-overexpressing tumor cells.
Cai L; Qiu N; Li X; Luo K; Chen X; Yang L; He G; Wei Y; Chen L
Int J Pharm; 2011 Apr; 408(1-2):173-82. PubMed ID: 21277964
[TBL] [Abstract][Full Text] [Related]
58. Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity.
Lee H; Lee K; Park TG
Bioconjug Chem; 2008 Jun; 19(6):1319-25. PubMed ID: 18481885
[TBL] [Abstract][Full Text] [Related]
59. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
60. The use of α-conotoxin ImI to actualize the targeted delivery of paclitaxel micelles to α7 nAChR-overexpressing breast cancer.
Mei D; Lin Z; Fu J; He B; Gao W; Ma L; Dai W; Zhang H; Wang X; Wang J; Zhang X; Lu W; Zhou D; Zhang Q
Biomaterials; 2015 Feb; 42():52-65. PubMed ID: 25542793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]